PET-MR can predict survival and response in advanced hepatocellular carcinoma patients treated with sorafenib

被引：0
|
作者：
Hwang, Jae-Pil [1 ]
Lim, Ilhan [1 ]
Han, Chul Ju [2 ]
Park, Su Cheol [2 ]
Kim, Young Han [3 ]
Park, Joon Yeun [1 ]
Kim, Kyeong Min [1 ]
Kim, Byung Il [1 ]
Choi, Chang Woon [1 ]
Lim, Sang Moo [1 ]
机构：
[1] Korea Canc Ctr Hosp, Nucl Med, Seoul, South Korea
[2] Korea Canc Ctr Hosp, Internal Med, Seoul, South Korea
[3] Korea Canc Ctr Hosp, Radiol, Seoul, South Korea
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
61
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib
    Caputo, Francesco
    Dadduzio, Vincenzo
    Tovoli, Francesco
    Bertolini, Giulia
    Cabibbo, Giuseppe
    Cerma, Krisida
    Vivaldi, Caterina
    Faloppi, Luca
    Rizzato, Mario Domenico
    Piscaglia, Fabio
    Celsa, Ciro
    Fornaro, Lorenzo
    Marisi, Giorgia
    Conti, Fabio
    Silvestris, Nicola
    Silletta, Marianna
    Lonardi, Sara
    Granito, Alessandro
    Stornello, Caterina
    Massa, Valentina
    Astara, Giorgio
    Delcuratolo, Sabina
    Cascinu, Stefano
    Scartozzi, Mario
    Casadei-Gardini, Andrea
    PLOS ONE, 2020, 15 (05):
  • [2] Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with Sorafenib
    Antonelli, G.
    Gigante, E.
    Iavarone, M.
    Begini, P.
    Biondetti, P.
    Pellicelli, A. M.
    Sangiovanni, A.
    Lampertico, P.
    Marignani, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S207 - S208
  • [3] Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenib
    Otsuka, Taiga
    Eguchi, Yuichiro
    Kawazoe, Seiji
    Yanagita, Kimihiko
    Ario, Keisuke
    Kitahara, Kenji
    Kawasoe, Hiroaki
    Kato, Hiroyuki
    Mizuta, Toshihiko
    HEPATOLOGY RESEARCH, 2012, 42 (09) : 879 - 886
  • [4] Analysis of postprogression survival of patients with advanced hepatocellular carcinoma treated with sorafenib
    Wada, Y.
    Takami, Y.
    Matsushima, H.
    Ryu, T.
    Mikagi, K.
    Saitsu, H.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S630 - S631
  • [5] Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Antonelli, G.
    Gigante, E.
    Iavarone, M.
    Begini, P.
    Sangiovanni, A.
    Iannicelli, E.
    Biondetti, P.
    Pellicelli, A. M.
    Miglioresi, L.
    Marchetti, P.
    Lampertico, P.
    Marignani, M.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 14 - 14
  • [6] Can alfa-fetoprotein response to sorafenib predict for response and overall survival in hepatocellular carcinoma?
    Durrani, Humdum Pasha
    Murthy, Hemant S.
    Sanaka, Sirish
    Punja, Punam
    Naidu, Salini Sathya
    Atluri, Prashanti
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Impact of statin on the survival of patients with advanced hepatocellular carcinoma treated with sorafenib or lenvatinib
    Cho, Hyo Jung
    Han, Ji Eun
    Cheong, Jae Youn
    Kim, Soon Sun
    JOURNAL OF HEPATOLOGY, 2023, 78 : S572 - S572
  • [8] Relationship of ethnicity and overall survival in patients treated with sorafenib for advanced hepatocellular carcinoma
    Peixoto, Renata D'Alpino
    Renouf, Daniel J.
    Gill, Sharlene
    Cheung, Winson Y.
    Lim, Howard J.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 5 (04) : 259 - 264
  • [9] The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib
    Han, Ji Eun
    Kim, Jisu
    Cheong, Jae Youn
    Kim, Soon Sun
    Lim, Sun Gyo
    Yang, Min Jae
    Noh, Choong-Kyun
    Lee, Gil Ho
    Eun, Jung Woo
    Park, Bumhee
    Cho, Hyo Jung
    CANCERS, 2024, 16 (02)
  • [10] IMPACT OF SARCOPENIA ON SURVIVAL OF PATIENTS AFFECTED BY ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
    Reggidori, N.
    Lani, L.
    Renzulli, M.
    Gramenzi, A.
    Iannone, G.
    Granito, A.
    Piscaglia, F.
    Golfieri, R.
    Trevisani, F.
    Biselli, M.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S151 - S151
12345